Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease

Clinical trial NCT01249820 · COMPLETED

Trial details

NCT number: NCT01249820
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndrome Leukemia, Myeloid, Acute

Start date: 2010-11-01
Primary completion: 2013-01-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.